e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Marc Humbert, Harrison W. Farber, Hossein-Ardeschir Ghofrani, Raymond L. Benza, Dennis Busse, Christian Meier, Marius M. Hoeper
Source:
Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Journal Issue:
June
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marc Humbert, Harrison W. Farber, Hossein-Ardeschir Ghofrani, Raymond L. Benza, Dennis Busse, Christian Meier, Marius M. Hoeper. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018
Year: 2018
Risk assessment in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 390-398
Year: 2016
Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017
Year: 2018
Chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension
Year: 2015
Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (1) 1801915; 10.1183/13993003.01915-2018
Year: 2019
Chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
Chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010
Predictors of physical activity in pulmonary arterial and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019
ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020
Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020
Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 637-648
Year: 2004
Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept